Indications
- Coronary heart disease, PTCA, STENT and rotablation including post heart attack
- Status following coronary artery bypass surgery, minimally invasive coronary surgery, and myocardial laser revascularization
- Acquired heart valve defects
- Status following heart valve replacement or reconstruction, removal of benign heart tumors
- Status following peri- or myocarditis
- Cardiomyopathy and status following myectomy or selective infarction by HOCM
- Heart rhythm disturbances and status following intervention (ablation, pacemakers, AICD)
- Status following heart transplantation, heart failure stages l - III NYHA
- High blood pressure and high pressure diseases including hypertensive heart disease
- Arterial occlusive disease stages l - III according to Fontaine
- Venous diseases and status following pulmonary embolism and pulmonary hypertension
- Psychovegetative syndromes with cardiovascular symptoms
- Older patients with multiple chronic disorders
- Inflammatory rheumatic diseases
- Selected endocrine disorders (thyroid metabolic disorders)
- Diabetes mellitus type I and II
- Obesity
- Hyperlipidemia
- Hyperuricemia
- Gout, metabolic syndrome
- Rehabilitation of patients with impaired ventricular function and significant peripheral performance limitations
- Rehabilitation of patients with disease coping problems (coping deficits)
- Rehabilitation of patients in preparation for heart surgery
- Rehabilitation of patients with concurrent neurological illness (brain disorders, even after resuscitation, specific therapeutic setting at a special ward)
- Rehabilitation of patients with concurrent orthopedic disease
|